2
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Breast Neoplasms
25
Neoplasms
12
Giant Cell Tumor of Bone
10
Prostatic Neoplasms
9
Multiple Myeloma
9
Neoplasm Metastasis
8
Osteoporosis
4
Fractures, Bone
4
Carcinoma, Non-Small-Cell Lung
4
Recurrence
3
Kidney Neoplasms
3
Carcinoma, Renal Cell
3
Bone Neoplasms
3
Bone Diseases, Metabolic
3
Bone Diseases
3
Spinal Cord Compression
2
Smoldering Multiple Myeloma
2
Parathyroid Neoplasms
2
Melanoma
2
Lymphoma
2
Lung Neoplasms
2
Giant Cell Tumors
2
Bone Metastases
2
Bone Cysts, Aneurysmal
2
With MSS/pMMR Advanced, Platinum-resistant Ovarian Cancer
1
Urinary Bladder Neoplasms
1
Ureteral Neoplasms
1
Thyroid Neoplasms
1
Thyroid Cancer Metastatic
1
Paraproteinemias
1
Interventions
Self-Management
1
Saline Solution
1
Lysine Acetyltransferase 5
1
Levobupivacaine
1
Hypnosis
1
Furosemide
1
Duloxetine Hydrochloride
1
Diphosphonates
1
Denosumab
1
Cryotherapy
1
Auriculotherapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Musculoskeletal Pain
×
Denosumab
×
Clear all
NCT03811509
2019-01-28
B-ABLE
Parc de Salut Mar
Phase 4
Unknown
1,000 enrolled